Kelly E A, Colley D G
Department of Microbiology, Vanderbilt University School of Medicine, Nashville, TN 37212.
J Immunol. 1988 Apr 15;140(8):2737-45.
Mice can be partially protected against challenge infections of Schistosoma mansoni cercariae by either single or multiple exposure to irradiated cercariae (x-cerc). The participation of L3T4+ lymphocytes on this resistance phenomenon was evaluated by selectively depleting this cell population through in vivo administration of mAb anti-L3T4 (hybridoma GK 1.5) at three different times in relationship to the challenge infections. Treatment with anti-L3T4 before challenge such that depletion was effective during the time of cercarial skin penetration and dermal/s.c. residence significantly reduced the level of resistance induced by x-cerc sensitization. When treatment was delayed until after challenge, depletion of L3T4+ cells coincided with either the lung or post-lung/liver phases of schistosomular migration, and normal levels of x-cerc-induced resistance were induced. In contrast to once-immunized mice, mice hyperimmunized by five exposures to x-cerc and then depleted of L3T4+ cells at the time of challenge (skin phase) still expressed resistance to the challenge. These data suggest that when mice are sensitized only once with x-cerc the challenge infection provides a necessary immunologic boost which requires L3T4+ cells for effective expression of resistance. The requirement for this anamnestic effect by the challenge infection can be circumvented by hyperimmunization. Evaluation of the immune response of one-time sensitized or hyperimmunized mice demonstrated that cellular Ag-specific proliferative responses and mitogen-induced lymphokine production were abrogated after any of the various in vivo regimens of anti-L3T4 antibody. In contrast, immunoblot analysis of humoral responsiveness revealed a correlation between the expression of resistance and the ability of sera from immunized and anti-L3T4 treated mice to recognize a 75-kDa parasite antigenic component.
单次或多次暴露于经辐照的曼氏血吸虫尾蚴(x尾蚴),可使小鼠在一定程度上抵御曼氏血吸虫尾蚴的攻击感染。通过在与攻击感染相关的三个不同时间点体内注射抗L3T4单克隆抗体(杂交瘤GK 1.5)选择性清除该细胞群体,评估了L3T4 +淋巴细胞在这种抗性现象中的作用。在攻击前用抗L3T4进行治疗,使在尾蚴皮肤穿透和真皮/皮下停留期间清除有效,这显著降低了x尾蚴致敏诱导的抗性水平。当治疗延迟到攻击后时,L3T4 +细胞的清除与血吸虫迁移的肺部或肺部/肝脏后阶段同时发生,并且诱导了正常水平的x尾蚴诱导抗性。与单次免疫的小鼠不同,经五次暴露于x尾蚴超免疫然后在攻击时(皮肤阶段)清除L3T4 +细胞的小鼠仍表现出对攻击的抗性。这些数据表明,当小鼠仅用x尾蚴致敏一次时,攻击感染提供了必要的免疫增强,这需要L3T4 +细胞来有效表达抗性。超免疫可规避攻击感染对这种回忆效应的需求。对单次致敏或超免疫小鼠的免疫反应评估表明,在任何体内抗L3T4抗体治疗方案后,细胞抗原特异性增殖反应和丝裂原诱导的淋巴因子产生均被消除。相比之下,体液反应性的免疫印迹分析显示,抗性表达与免疫和抗L3T4处理小鼠血清识别75 kDa寄生虫抗原成分的能力之间存在相关性。